• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, June 17, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Eyes an ‘important route’ for coronavirus transmission

by Myles Hume
May 12, 2020
in International, News, Ophthalmology, Optometry, Research
Reading Time: 3 mins read
A A
The researchers have become the first to show that coronavirus can infect through two facial entry points.

The researchers have become the first to show that coronavirus can infect through two facial entry points.

Share on FacebookShare on Twitter

Public health researchers believe the eye may be a key entry point for coronavirus to infect the body, in a world-first study that reveals the current strain is up to 100 times more infectious than SARS.

New testing data published in The Lancet Respiratory Medicine this month has demonstrated that SARS-Cov-2 – the strain of coronavirus that causes COVID-19 disease – infected the upper respiratory airways and conjunctiva much more efficiently than the 2003 SARS-CoV (SARS).

The researchers from the School of Public Health, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), claim they are the first in the world to provide evidence that coronavirus can infect through both facial entry points.

More reading: Study findings suggest coronavirus replicates in the eye

In this study, co-author Dr Michael Chan Chi-wai, associate professor of the School of Public Health, HKUMed, and his research team compared the infection of SARS-CoV-2, SARS-CoV and the influenza viruses H5N1 (bird flu) and H1N1pdm2009 (swine flu) using human upper respiratory tract and eye tissues.

“We found that SARS-Cov-2 is much more efficient in infecting the human conjunctiva, the cells lining the surfaces of the eyes,  and the upper respiratory airways than Sars, with virus level some 80 to 100 times higher,” Chan said told the South China Morning Post, adding that its level of infection is comparable to that observed with swine flu.

The HKUMed research team (from left to right) Professor Malik Peiris; Tam Wah-Ching, professor in medical science and chair professor of virology, School of Public Health; Professor John Nicholls, clinical professor, Department of Pathology; Dr Michael Chan Chi-wai, associate professor, School of Public Health; and Dr Kenrie Hui Pui-yan, research assistant professor, School of Public Health. Image: HKUMed

“This explains the higher transmissibility of COVID-19 than that of Sars. This study also highlights the fact that eyes may be an important route of SARS-CoV-2 human infection.”

Taken together, the researchers say this explains the higher transmissibility of the novel pandemic SARS-CoV-2 than that of SARS-CoV.

In a previous study, the research team discovered that SARS-CoV-2 can remain alive for several days on smooth surfaces such as stainless steel, glass and plastic.

The latest findings highlight the possibility that infectious virus can be spread from such contaminated surfaces by hands, when a person touches the surfaces and rubs their eyes afterwards.

This, the researchers state, demonstrates why it is vital to avoid touching the eyes when in public areas, and the importance of regular hand washing to prevent accidental transfer of SARS-CoV-2 from contaminated surfaces to human eyes and noses.

“There is a need for studies like those done by this research team, which are inclusive of diverse viruses previously associated with human pandemics, and viruses believed to have the potential to do so, that use a range of relevant respiratory and non-respiratory tissue and cell types that might support virus replication following multiple exposure routes,” Dr Jessica Belser, an epidemiological expert from the National Center for Immunization and Respiratory Diseases (NCIRD), the Centers for Disease Control and Prevention (CDC), said.

“These laboratory studies provide crucial context for interpretation of what makes each virus unique and how best to develop medical countermeasures to improve human health.”

This image shows the coronavirus and influenza virus infected cells (in red colour) in human bronchus, lung and conjunctiva in explants culture. Image: HKUMed
Tags: conjunctivacoronavirusCOVID-19Dr Michael Chan Chi-waieyesH1N1pdm2009H5N1HKUMedLKS Faculty of Medicine of the University of Hong KongPublic healthrespiratory airwaysSarsSARS-CoV-2School of Public HealthThe Lancet Respiratory Medicine

Related Posts

The brand is renowned for “signature artisanal craftsmanship and precise engineering”. Image: Safilo.

Safilo launches Stuart Weitzman eyewear in Australia

by Staff Writer
June 17, 2025

Stuart Weitzman has expanded its global luxury brand footprint with a first eyewear collection available to Australian independent optical practices...

The Eyerising device is reported to be the only red-light device with international regulatory approval outside of China. Image: Eyerising International.

Inclusion of red-light therapy in WSPOS 2025 Myopia Consensus Statement

by Myles Hume
June 16, 2025

Repeated low-level red-light (RLRL) therapy has been included in the 2025 Myopia Consensus Statement released by the World Society of...

Design Eyewear Group took over the brands from 10 June 2025. Images: Design Eyewear Group.

Design Eyewear Group acquires Menrad; licensing agreements with Jaguar, JOOP!, Morgan

by Staff Writer
June 16, 2025

Design Eyewear Group (DEG) – behind many iconic eyewear brands found in Australian independent optical practices – has acquired the...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited